Skip to main content
VERU INC. logo

VERU INC. — Investor Relations & Filings

Ticker · VERU ISIN · US92536C1036 LEI · 529900ER63TFLEIJV631 US Manufacturing
Open in API
Filings indexed 1,020 across all filing types
Latest filing 2025-12-17 Earnings Release
Country US United States of America
Listing US VERU

About VERU INC.

https://verupharma.com/

Veru Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for cardiometabolic and inflammatory diseases. The company's primary development programs address high-quality weight loss and atherosclerotic coronary artery disease. Its lead candidate, enobosarm, is a novel, oral selective androgen receptor modulator (SARM) designed to prevent muscle loss in patients undergoing weight loss therapy with GLP-1 receptor agonists. Veru is also advancing sabizabulin, an oral broad anti-inflammatory agent, for the treatment of atherosclerotic coronary artery disease.

Recent filings

Filing Released Lang Actions
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 17, 2025, reporting the results of operations and financial condition for the year ended September 30, 2025. It specifically states that it includes a press release announcing the results for the fiscal year. The document is relatively short (3449 characters) and the main content is a press release attached as an exhibit. The Form 8-K is used for current reports and often includes earnings releases or other significant events. The key phrase 'announcing results for the year ended September 30, 2025' and the presence of a press release indicate this is an Earnings Release (ER) rather than a full Annual Report (10-K) or Interim Report (IR). The document does not contain full financial statements or detailed analysis, just the announcement of results. Therefore, the correct classification is Earnings Release (ER).
2025-12-17 English
S-8 Filing
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Veru Inc. on December 17, 2025. It registers additional shares under the company's 2018 Equity Incentive Plan, reflecting a reverse stock split adjustment. The document includes incorporation by reference of prior filings, exhibits such as amended articles of incorporation, consents, and powers of attorney. It is a registration statement related to securities issuance under an equity incentive plan, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration filing itself. Form S-8 is a specific SEC registration form for securities to be offered under employee benefit plans. Therefore, this filing is best classified under Regulatory Filings (RNS) as it does not fit other categories like capital/financing update or share issue/capital change, which are more specific to announcements rather than registration statements.
2025-12-17 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-09 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-09 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-09 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-09 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.